Natixis Advisors, L.P. Zoetis Inc. Transaction History

Natixis Advisors, L.P.

$51.3 Billion
Q3 2024

A detailed history of Natixis Advisors, L.P. transactions in Zoetis Inc. stock. As of the latest transaction made, Natixis Advisors, L.P. holds 1,121,306 shares of ZTS stock, worth $194 Million. This represents 0.43% of its overall portfolio holdings.

Number of Shares

1,121,306

Previous 1,088,899 2.98%

Holding current value

$194 Million

Previous $189 Million 16.06%

% of portfolio

0.43%

Previous 0.41%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	BUY	$172.58 - $196.48 $5.59 Million - $6.37 Million	32,407 Added 2.98%	1,121,306 $219 Million
Q2 2024 Aug 01, 2024	BUY	$145.54 - $178.83 $7.83 Million - $9.63 Million	53,831 Added 5.2%	1,088,899 $189 Million
Q1 2024 Apr 25, 2024	BUY	$165.67 - $199.94 $15.4 Million - $18.5 Million	92,655 Added 9.83%	1,035,068 $175 Million
Q4 2023 Feb 06, 2024	BUY	$151.44 - $200.09 $180,819 - $238,907	1,194 Added 0.13%	942,413 $186 Million
Q3 2023 Nov 13, 2023	BUY	$167.14 - $192.77 $55.1 Million - $63.5 Million	329,543 Added 53.88%	941,219 $164 Million
Q2 2023 Aug 15, 2023	BUY	$160.94 - $186.23 $3.71 Million - $4.3 Million	23,075 Added 3.92%	611,676 $105 Million
Q1 2023 May 11, 2023	BUY	$145.48 - $175.02 $13.9 Million - $16.8 Million	95,830 Added 19.45%	588,601 $98 Million
Q4 2022 Jan 27, 2023	BUY	$131.14 - $157.47 $8.98 Million - $10.8 Million	68,454 Added 16.13%	492,771 $72.2 Million
Q3 2022 Nov 14, 2022	SELL	$148.29 - $182.55 $849,108 - $1.05 Million	-5,726 Reduced 1.33%	424,317 $62.9 Million
Q2 2022 Aug 12, 2022	BUY	$155.97 - $200.09 $8.22 Million - $10.5 Million	52,674 Added 13.96%	430,043 $73.9 Million
Q1 2022 May 12, 2022	SELL	$181.39 - $234.03 $2.04 Million - $2.63 Million	-11,256 Reduced 2.9%	377,369 $71.2 Million
Q4 2021 Feb 08, 2022	BUY	$193.69 - $247.03 $3.67 Million - $4.68 Million	18,955 Added 5.13%	388,625 $94.8 Million
Q3 2021 Nov 15, 2021	SELL	$189.29 - $209.69 $2.87 Million - $3.18 Million	-15,167 Reduced 3.94%	369,670 $71.8 Million
Q2 2021 Aug 12, 2021	BUY	$155.9 - $187.99 $4.26 Million - $5.14 Million	27,350 Added 7.65%	384,837 $71.7 Million
Q1 2021 May 05, 2021	SELL	$144.0 - $169.39 $460,224 - $541,370	-3,196 Reduced 0.89%	357,487 $56.3 Million
Q4 2020 Feb 12, 2021	BUY	$157.07 - $174.35 $12.9 Million - $14.3 Million	82,047 Added 29.45%	360,683 $59.7 Million
Q3 2020 Nov 12, 2020	SELL	$137.1 - $165.37 $416,098 - $501,897	-3,035 Reduced 1.08%	278,636 $46.1 Million
Q2 2020 Aug 11, 2020	BUY	$111.92 - $142.53 $5.76 Million - $7.33 Million	51,462 Added 22.35%	281,671 $38.6 Million
Q1 2020 Apr 27, 2020	BUY	$92.66 - $144.94 $2.24 Million - $3.51 Million	24,225 Added 11.76%	230,209 $27.1 Million
Q4 2019 Feb 10, 2020	BUY	$116.25 - $133.25 $403,271 - $462,244	3,469 Added 1.71%	205,984 $27.3 Million
Q3 2019 Nov 12, 2019	BUY	$112.57 - $128.43 $112,119 - $127,916	996 Added 0.49%	202,515 $25.2 Million
Q2 2019 Aug 12, 2019	SELL	$97.98 - $114.28 $260,626 - $303,984	-2,660 Reduced 1.3%	201,519 $22.9 Million
Q1 2019 May 15, 2019	BUY	$81.56 - $100.67 $795,699 - $982,136	9,756 Added 5.02%	204,179 $20.6 Million
Q4 2018 Feb 13, 2019	SELL	$79.28 - $95.27 $137,233 - $164,912	-1,731 Reduced 0.88%	194,423 $16.6 Million
Q3 2018 Nov 13, 2018	BUY	$83.5 - $93.23 $1.26 Million - $1.41 Million	15,136 Added 8.36%	196,154 $18 Million
Q2 2018 Aug 14, 2018	BUY	$79.9 - $89.2 $2.26 Million - $2.52 Million	28,223 Added 18.47%	181,018 $0
Q1 2018 May 10, 2018	BUY	$71.51 - $84.69 $1.31 Million - $1.55 Million	18,353 Added 13.65%	152,795 $12.8 Million
Q4 2017 Feb 14, 2018	SELL	$63.24 - $72.8 $1.27 Million - $1.47 Million	-20,134 Reduced 13.03%	134,442 $9.69 Million
Q3 2017 Nov 14, 2017	BUY	$59.73 - $65.4 $9.23 Million - $10.1 Million	154,576	154,576 $9.86 Million

Others Institutions Holding ZTS

# of Institutions

1,957

Shares Held

408M

Call Options Held

1.02M

Put Options Held

1.09M

View Full List

About Zoetis Inc.

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $80.9B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

More about ZTS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Natixis Advisors, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Natixis Advisors, L.P. with notifications on news.

Account

Natixis Advisors, L.P. Zoetis Inc. Transaction History